PIPC Reminds Democrats The Party Promised To Not Use QALYs

In preparation for a Senate hearing that will highlight lower foreign drug prices, a coalition that includes drug makers and patients is reminding Democrats that their 2020 party platform opposes using a metric that is key to drug-value assessments: quality-adjusted life years (QALY). On Tuesday (March 23), the labor subcommittee of the Senate health committee will hold a hearing titled, “Why Does the US Pay the Highest Prices in the World for Prescription Drugs?” The hearing, scheduled by subcommittee Chair...